Christian Antoni - Concepedia

Author

Christian Antoni

Friedrich-Alexander-Universität Erlangen-Nürnberg

Also Known As

C ANTONI, C Antoni, C E ANTONI, C E Antoni, C. Antoni, C.E. Antoni, CHRISTIAN E. ANTONI, Christian Antoni, Christian E Antoni, Christian E. Antoni

Publications

14K

Citations

H-Index

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg University of California San Diego University of Toronto Leiden University University of Massachusetts Chan Medical School

About

Christian Antoni is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, immunology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	4K
2	Allergy	3	3	525
3	Public Health	1	1	13
4	Allergy Medicine	1	1	190
5	Epidemiology	1	1	13

Christian Antoni

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis Michael J. Elliott, Ravinder N. Maini, Marc Feldmann, The Lancet InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic Diseases	1994	1.7K
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Arthritis & Rheumatism	1998	1.6K
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, New England Journal of Medicine	2018	1.1K
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja, Science Translational Medicine	2010	858
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial Christian Antoni, Gerald G. Krueger, Kurt de Vlam, Annals of the Rheumatic Diseases	2005	704
Infections in patients with rheumatoid arthritis treated with biologic agents Joachim Listing, Anja Strangfeld, S. Kary, Arthritis & Rheumatism	2005	684
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Christian Antoni, Arthur Kavanaugh, Bruce Kirkham, Arthritis & Rheumatism	2005	636
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. P. Charles, M. J. Elliott, Diana Davis, PubMed ImmunologyImmune RegulationAcute-phase ProteinsInflammatory ArthritisInflammation	1999	533
Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis Jeffry Katz, Christian Antoni, Gregory F. Keenan, The American Journal of Gastroenterology	2004	466
Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis P. Charles, Michael J. Elliott, Diana Davis, The Journal of Immunology ImmunologyImmune RegulationAcute-phase ProteinsAnti-tnf-α TherapyInnate Immunity	1999	433

Page 1